Your browser doesn't support javascript.
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.
Korobelnik, Jean-François; Loewenstein, Anat; Eldem, Bora; Joussen, Antonia M; Koh, Adrian; Lambrou, George N; Lanzetta, Paolo; Li, Xiaoxin; Lövestam-Adrian, Monica; Navarro, Rafael; Okada, Annabelle A; Pearce, Ian; Rodríguez, Francisco J; Wong, David T; Wu, Lihteh.
  • Korobelnik JF; Service d'ophtalmologie, CHU Bordeaux, Bordeaux, France. jean-francois.korobelnik@chu-bordeaux.fr.
  • Loewenstein A; Inserm, Bordeaux Population Health Research Center, team LEHA, Université de Bordeaux, UMR 1219, F-33000, Bordeaux, France. jean-francois.korobelnik@chu-bordeaux.fr.
  • Eldem B; Division of Ophthalmology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Joussen AM; Department of Ophthalmology, Hacettepe University, Ankara, Turkey.
  • Koh A; Charité - University Medicine Berlin, Berlin, Germany.
  • Lambrou GN; Eye and Retina Surgeons, Camden Medical Centre, Singapore, Singapore.
  • Lanzetta P; Global Medical Affairs Ophthalmology, Bayer, Basel, Switzerland.
  • Li X; Department of Medicine - Ophthalmology, University of Udine, Udine, Italy.
  • Lövestam-Adrian M; Department of Ophthalmology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Ospedale Santa Maria della Misericordia, Udine, Italy.
  • Navarro R; Istituto Europeo di Microchirurgia Oculare, IEMO, Udine, Italy.
  • Okada AA; Eye Center and Eye Institute, Peking University People's Hospital, Beijing, China.
  • Pearce I; Department of Ophthalmology, Lund University Hospital, Lund, Sweden.
  • Rodríguez FJ; Instituto Microcirugia Ocular, Barcelona, Spain.
  • Wong DT; Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
  • Wu L; Royal Liverpool University Hospital, Liverpool, UK.
Graefes Arch Clin Exp Ophthalmol ; 258(6): 1149-1156, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-121183
Semantic information from SemMedBD (by NLM)
1. Retinal Diseases PROCESS_OF Patients
Subject
Retinal Diseases
Predicate
PROCESS_OF
Object
Patients
2. Retinal Diseases COEXISTS_WITH COVID-19
Subject
Retinal Diseases
Predicate
COEXISTS_WITH
Object
COVID-19
3. Triage PREDISPOSES Blindness
Subject
Triage
Predicate
PREDISPOSES
Object
Blindness
4. Treatment Protocols ADMINISTERED_TO Ophthalmologist (occupation)
Subject
Treatment Protocols
Predicate
ADMINISTERED_TO
Object
Ophthalmologist (occupation)
5. Retinal Diseases PROCESS_OF Patients
Subject
Retinal Diseases
Predicate
PROCESS_OF
Object
Patients
6. Retinal Diseases COEXISTS_WITH COVID-19
Subject
Retinal Diseases
Predicate
COEXISTS_WITH
Object
COVID-19
7. Triage PREDISPOSES Blindness
Subject
Triage
Predicate
PREDISPOSES
Object
Blindness
8. Treatment Protocols ADMINISTERED_TO Ophthalmologist (occupation)
Subject
Treatment Protocols
Predicate
ADMINISTERED_TO
Object
Ophthalmologist (occupation)
ABSTRACT

PURPOSE:

There is an urgent need to address how to best provide ophthalmic care for patients with retinal disease receiving intravitreal injections with anti-vascular endothelial growth factor agents during the ongoing global COVID-19 pandemic. This article provides guidance for ophthalmologists on how to deliver the best possible care for patients while minimizing the risk of infection.

METHODS:

The Vision Academy's Steering Committee of international retinal disease experts convened to discuss key considerations for managing patients with retinal disease during the COVID-19 pandemic. After reviewing the existing literature on the issue, members put forward recommendations that were systematically refined and voted on to develop this guidance.

RESULTS:

The considerations focus on the implementation of steps to minimize the exposure of patients and healthcare staff to COVID-19. These include the use of personal protective equipment, adherence to scrupulous hygiene and disinfection protocols, pre-screening to identify symptomatic patients, and reducing the number of people in waiting rooms. Other important measures include triaging of patients to identify those at the greatest risk of irreversible vision loss and prioritization of treatment visits over monitoring visits where possible. In order to limit patient exposure, ophthalmologists should refrain from using treatment regimens that require frequent monitoring.

CONCLUSION:

Management of patients with retinal disease receiving intravitreal injections during the COVID-19 pandemic will require adjustment to regular clinical practice to minimize the risk of exposure of patients and healthcare staff, and to prioritize those with the greatest medical need. The safety of patients and healthcare staff should be of paramount importance in all decision-making.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ophthalmology / Pneumonia, Viral / Retinal Diseases / Coronavirus Infections / Vascular Endothelial Growth Factor A / Intravitreal Injections / Pandemics Type of study: Clinical Practice Guide / Prognostic study Limits: Humans Language: English Journal: Graefes Arch Clin Exp Ophthalmol Year: 2020 Document Type: Article Affiliation country: S00417-020-04703-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ophthalmology / Pneumonia, Viral / Retinal Diseases / Coronavirus Infections / Vascular Endothelial Growth Factor A / Intravitreal Injections / Pandemics Type of study: Clinical Practice Guide / Prognostic study Limits: Humans Language: English Journal: Graefes Arch Clin Exp Ophthalmol Year: 2020 Document Type: Article Affiliation country: S00417-020-04703-x